help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koppelman, M. C.
Right arrow Articles by Deuster, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koppelman, M. C.
Right arrow Articles by Deuster, P.

Journal of Clinical Endocrinology & Metabolism, Vol 68, 215-218, Copyright © 1989 by Endocrine Society

ARTICLES

Zinc does not acutely suppress prolactin in normal or hyperprolactinemic women

MC Koppelman, V Greenwood, J Sohn and P Deuster
Department of Medicine, Brown University, Miriam Hospital, Providence, Rhode Island 02906.

In rat pituitary cells in vitro physiological zinc concentrations selectively inhibit basal and stimulated PRL release. This study was done to investigate the serum PRL response to an oral zinc challenge in vivo. Eight hyperprolactinemic [mean serum PRL, 76.0 +/- 43.8 (+/- SD) micrograms/L] and 10 normal (mean serum PRL, 9.6 +/- 2.8 micrograms/L) women were studied. All women had normal thyroid, renal, and hepatic function, and none was taking any medications. Each was studied twice, after both oral zinc (50 mg) and placebo, given in random order. Blood was withdrawn every 15 min from 30 min before to 210 min after zinc or placebo administration; TRH (500 micrograms) was given iv at 180 min. Both hyperprolactinemic and normal women absorbed the zinc well, achieving similar maximal plasma zinc levels [hyperprolactinemic women, 39.5 +/- 6.9 (+/- SD) mumol/L; normal women, 33.3 +/- 7.0; P less than 0.001 vs. placebo]. When 2 women who became symptomatic after zinc administration were excluded, there were no significant differences in basal or TRH-stimulated serum PRL levels after zinc vs. placebo. These findings indicate that zinc is not involved in the acute in vivo regulation of PRL secretion in humans.


This article has been cited by other articles:


Home page
 J Hum LactHome page
C. E. O'Brien, N. F. Krebs, J. L. Westcott, and Fang Dong
Relationships Among Plasma Zinc, Plasma Prolactin, Milk Transfer, and Milk Zinc in Lactating Women
J Hum Lact, May 1, 2007; 23(2): 179 - 183.
[Abstract] [PDF]

Home page
 EndocrinologyHome page
B. Tsunekawa, M. Wada, M. Ikeda, H. Uchida, N. Naito, and M. Honjo
The 20-Kilodalton (kDa) Human Growth Hormone (hGH) Differs from the 22-kDa hGH in the Effect on the Human Prolactin Receptor
Endocrinology, September 1, 1999; 140(9): 3909 - 3918.
[Abstract] [Full Text]

Home page
 ScienceHome page
B. Cunningham, S Bass, G Fuh, and J. Wells
Zinc mediation of the binding of human growth hormone to the human prolactin receptor
Science, December 21, 1990; 250(4988): 1709 - 1712.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
Q. R. Fan, E. O. Long, and D. C. Wiley
Cobalt-mediated Dimerization of the Human Natural Killer Cell Inhibitory Receptor
J. Biol. Chem., July 28, 2000; 275(31): 23700 - 23706.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society